Skip to content
10-K

Annual Report

CEREBAIN BIOTECH CORP.

0001477932-17-004520

← back to feed
Filed
Sep 15, 2017 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2017 · Sep 15, 2017 8.12M sh
Operating Cash Flow FY 2017 · Jun 30, 2016 −$564.95K
Current Liabilities FY 2017 · Jun 30, 2016 $1.09M
Total Liabilities FY 2017 · Jun 30, 2016 $3.54M
Current Assets FY 2017 · Jun 30, 2016 $495.94K
Total Assets FY 2017 · Jun 30, 2016 $495.94K
Sga Expense restated FY 2017 · Jun 30, 2016 $1.46M
Rd Expense FY 2017 · Jun 30, 2016 $177.52K
Net Income FY 2017 · Jun 30, 2016 −$2.42M
Operating Income FY 2017 · Jun 30, 2016 −$2.42M